GENESEN
Latest round
- Series A
Last raised
- Dec 2021
Total raised
- $5M
Investors
- 2
About GENESEN
Founded in 2018, Genesen operates from its headquarters in Seoul, South Korea.Genesen Bio specializes in providing advanced biotechnological solutions aimed at enhancing health and wellness through its core product offerings. The company’s main focus is on innovative biopharmaceuticals and diagnostic tools designed to address specific health challenges, particularly in the realms of chronic diseases and preventative healthcare. These products are engineered to integrate seamlessly into existing healthcare frameworks, offering end users—ranging from hospitals to individual patients—effective solutions for monitoring and managing health conditions.The revenue generation model of Genesen Bio is structured around a combination of direct sales and strategic partnerships within the healthcare sector. The company typically engages in B2B transactions, offering its products to hospitals and clinics that utilize them in patient care. Pricing plans are developed based on the specific needs of healthcare institutions, with flagship products providing significant value through their unique capabilities. These transactions are often facilitated through long-term contracts and subscription models that ensure a steady revenue stream. The company is focused on launching new biopharmaceutical products that will cater to emerging health challenges. Additionally, Genesen aims to expand its market presence in Asia and continues to strengthen its foothold in North America and Europe by 2023, targeting specific healthcare institutions that align with its innovative offerings.
Who invested in GENESEN
2 investors across 1 round
See all investors in GENESEN
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 16, 2021
Amount
$5M
Investors
Questions about GENESEN
Who invested in GENESEN?
GENESEN has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GENESEN raised?
GENESEN has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did GENESEN last raise money?
GENESEN's most recent round on record is a Series A, in Dec 2021.
What does GENESEN do?
Founded in 2018, Genesen operates from its headquarters in Seoul, South Korea.
Where is GENESEN headquartered?
GENESEN is headquartered in Seoul, South Korea.
Which VCs invest in companies like GENESEN?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at GENESEN's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like GENESEN? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.